Literature DB >> 22863683

Cytochrome P450 2S1 depletion enhances cell proliferation and migration in bronchial epithelial cells, in part, through modulation of prostaglandin E(2) synthesis.

T W Madanayake1, T P Fidler, T M Fresquez, N Bajaj, A M Rowland.   

Abstract

Cytochromes P450 (P450s) contribute to the metabolic activation and inactivation of various endogenous substrates. Despite years of research, the physiological role of CYP2S1 remains unknown. CYP2S1 has demonstrated NADPH P450-reductase-independent metabolism of cyclooxygenase (COX)-derived prostaglandins [e.g., prostaglandin G(2) (PGG(2))] at nanomolar concentrations. Arachidonic acid is converted to prostaglandin precursors [PGG(2) and prostaglandin H(2) (PGH(2))] through COX. These precursors are used to synthesize numerous prostanoids, including PGE(2). Prostaglandin E(2) (PGE(2)) promotes cell proliferation and cell migration and inhibits apoptosis. CYP2S1 metabolism of PGG(2) presumably sequesters PGG(2) and PGH(2), making them unavailable for synthesis of prostanoids such as PGE(2). Whether CYP2S1 contributes to prostaglandin metabolism and influences cell physiological remains to be determined. The purpose of this study was to evaluate the physiological role of CYP2S1, if any, in human bronchial epithelial cells [SV40-derived bronchial epithelial cell line (BEAS-2B)]. To do this, we used small interfering RNA to deplete CYP2S1 mRNA and protein by approximately 75% and evaluated the impact of CYP2S1 depletion on cell proliferation and migration. CYP2S1 depletion enhanced both cell proliferation and migration in BEAS-2B cells. Consistent with the proposed role of CYP2S1 in PGE(2) synthesis, the reduction in CYP2S1 expression doubled intracellular PGE(2) levels. Pharmacological administration of PGE(2) enhanced cell proliferation in BEAS-2B cells but failed to promote migration. Our data reveal an important role for CYP2S1 in the regulation of cell proliferation and migration, occurring in part through modulation of prostaglandin synthesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22863683      PMCID: PMC3477203          DOI: 10.1124/dmd.112.046466

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  28 in total

1.  Identification of a novel dioxin-inducible cytochrome P450.

Authors:  Steven P Rivera; Sirkku T Saarikoski; Oliver Hankinson
Journal:  Mol Pharmacol       Date:  2002-02       Impact factor: 4.436

2.  Prostaglandin E2 increases growth and motility of colorectal carcinoma cells.

Authors:  H Sheng; J Shao; M K Washington; R N DuBois
Journal:  J Biol Chem       Date:  2001-03-12       Impact factor: 5.157

3.  Prostaglandin E(2) regulates wound closure in airway epithelium.

Authors:  U Savla; H J Appel; P H Sporn; C M Waters
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-03       Impact factor: 5.464

4.  Effects of prostaglandin E(2) on proliferation and apoptosis of epithelial ovarian cancer cells.

Authors:  A R Munkarah; R Morris; P Baumann; G Deppe; J Malone; M P Diamond; G M Saed
Journal:  J Soc Gynecol Investig       Date:  2002 May-Jun

5.  Prostaglandin E(2)-induced interleukin-6 release by a human airway epithelial cell line.

Authors:  S Tavakoli; M J Cowan; T Benfield; C Logun; J H Shelhamer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-01       Impact factor: 5.464

Review 6.  Cytochrome P450 pathways of arachidonic acid metabolism.

Authors:  Deanna L Kroetz; Darryl C Zeldin
Journal:  Curr Opin Lipidol       Date:  2002-06       Impact factor: 4.776

7.  Cytochrome P450 2S1 is reduced by NADPH-cytochrome P450 reductase.

Authors:  Yi Xiao; Raku Shinkyo; F Peter Guengerich
Journal:  Drug Metab Dispos       Date:  2011-03-23       Impact factor: 3.922

8.  Cutaneous expression of cytochrome P450 CYP2S1: individuality in regulation by therapeutic agents for psoriasis and other skin diseases.

Authors:  Gillian Smith; C Roland Wolf; Yusuf Y Deeni; Robert S Dawe; Alan T Evans; Muriel M Comrie; James Ferguson; Sally H Ibbotson
Journal:  Lancet       Date:  2003-04-19       Impact factor: 79.321

9.  Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy.

Authors:  Rama Pai; Brian Soreghan; Imre L Szabo; Meredith Pavelka; Dolgor Baatar; Andrzej S Tarnawski
Journal:  Nat Med       Date:  2002-03       Impact factor: 53.440

10.  Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor.

Authors:  F Gregory Buchanan; Dingzhi Wang; Francesca Bargiacchi; Raymond N DuBois
Journal:  J Biol Chem       Date:  2003-06-24       Impact factor: 5.157

View more
  10 in total

1.  Cyp2c44 regulates prostaglandin synthesis, lymphangiogenesis, and metastasis in a mouse model of breast cancer.

Authors:  Rushendhiran Kesavan; Timo Frömel; Sven Zukunft; Hebatullah Laban; Alexandra Geyer; Zumer Naeem; Juliana Heidler; Ilka Wittig; Eiman Elwakeel; Bernhard Brüne; Andreas Weigert; Rüdiger Popp; Ingrid Fleming
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-02       Impact factor: 11.205

2.  A Role for the Orphan Human Cytochrome P450 2S1 in Polyunsaturated Fatty Acid ω-1 Hydroxylation Using an Untargeted Metabolomic Approach.

Authors:  Mostafa I Fekry; Yi Xiao; Jeannette Zinggeler Berg; F Peter Guengerich
Journal:  Drug Metab Dispos       Date:  2019-09-11       Impact factor: 3.922

3.  Reduction of aromatic and heterocyclic aromatic N-hydroxylamines by human cytochrome P450 2S1.

Authors:  Kai Wang; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2013-05-29       Impact factor: 3.739

Review 4.  Epithelial Cells and Inflammation in Pulmonary Wound Repair.

Authors:  Amanda Croasdell Lucchini; Naomi N Gachanja; Adriano G Rossi; David A Dorward; Christopher D Lucas
Journal:  Cells       Date:  2021-02-05       Impact factor: 6.600

5.  Honeybee Pollen Extracts Reduce Oxidative Stress and Steatosis in Hepatic Cells.

Authors:  Juan Esteban Oyarzún; Marcelo E Andia; Sergio Uribe; Paula Núñez Pizarro; Gabriel Núñez; Gloria Montenegro; Raquel Bridi
Journal:  Molecules       Date:  2020-12-22       Impact factor: 4.411

6.  CYP2S1 and CYP2W1 expression is associated with patient survival in breast cancer.

Authors:  Radhika Aiyappa-Maudsley; Sarah J Storr; Emad A Rakha; Andrew R Green; Ian O Ellis; Stewart G Martin
Journal:  J Pathol Clin Res       Date:  2022-07-28

7.  CYP2S1 might regulate proliferation and immune response of keratinocyte in psoriasis.

Authors:  Yujun Sheng; Leilei Wen; Xiaodong Zheng; Mengqing Li; Dan Wang; Sixian Chen; Ran Li; Lili Tang; Fusheng Zhou
Journal:  Epigenetics       Date:  2020-09-12       Impact factor: 4.528

8.  A transcriptomic approach to elucidate the physiological significance of human cytochrome P450 2S1 in bronchial epithelial cells.

Authors:  Thushara W Madanayake; Ingrid E Lindquist; Nicholas P Devitt; Joann Mudge; Aaron M Rowland
Journal:  BMC Genomics       Date:  2013-11-26       Impact factor: 3.969

9.  Cyp2aa9 regulates haematopoietic stem cell development in zebrafish.

Authors:  Jingying Chen; Jianbo He; Li Li; Deqin Yang; Lingfei Luo
Journal:  Sci Rep       Date:  2016-05-20       Impact factor: 4.379

10.  Upregulation of CYP2S1 by oxaliplatin is associated with p53 status in colorectal cancer cell lines.

Authors:  Chao Yang; Qian Zhou; Minle Li; Xuemei Tong; Jiayi Sun; Yin Qing; Liya Sun; Xuhan Yang; Xiaowen Hu; Jie Jiang; Xiaomei Yan; Lin He; Chunling Wan
Journal:  Sci Rep       Date:  2016-09-09       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.